Should intravenous N-acetylcysteine be considered standard of care for prevention of radio-contrast-induced nephropathy?
Huxtable
Lindsay
L
Raney
Carrington R K
CR
Khera
Gordi S
GS
D000111:Acetylcysteine / Q000008:administration & dosage*; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic
D003287:Contrast Media; D000111:Acetylcysteine